A Study to Evaluate the Effect of Povorcitinib on the QT/QTc Interval in Healthy Participants
Clinical trial NCT06441318 · COMPLETED
Trial details
- NCT number
- NCT06441318
- Sponsor
- Incyte Corporation
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-12
- Primary completion
- 2024-09-10
- Enrollment
- 128
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.